| 231 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Radiotherapy and Nuclear medicine |
2021 |
| 232 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Radiotherapy and Nuclear medicine |
2021 |
| 233 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 234 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 235 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 236 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 237 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 238 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 239 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 240 |
Micro-RNA 155 in non-Hodgkin lymphoma |
Department of Clinical Pathology |
2021 |
